Literature DB >> 19570493

Phenotypic approach to the management of chronic prostatitis/chronic pelvic pain syndrome.

J Curtis Nickel1, Daniel Shoskes.   

Abstract

There is no one unifying etiological mechanism or specific curative therapy for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). However, there is sufficient evidence to suggest that each of the proposed mechanisms may be important in some patients, and that many of our evaluated treatments do in fact work in subgroups of patients. We hypothesize that CP/CPPS patients are not a homogenous group suffering from a single disease entity. Rather, CP/CPPS patients are actually unique individuals with differing clinical phenotypes based on various etiological mechanisms with distinctive symptom complexes and progression trajectories. We call this the "Snow Flake Hypothesis." We propose the UPOINT (urinary, psychosocial, organ-specific, infection, neurologic/systemic, and tenderness domains) clinical phenotyping classification; we have validated the concept in a CP/CPPS cohort and have suggested that phenotypically directed therapy will improve our clinical treatment outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 19570493     DOI: 10.1007/s11934-009-0050-7

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  23 in total

1.  A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS).

Authors:  Volkan Tuğcu; Ali Ihsan Taşçi; Adem Fazlioğlu; Gökhan Gürbüz; Emin Ozbek; Selçuk Sahin; Fatih Kurtuluş; Mete Cek
Journal:  Eur Urol       Date:  2006-10-17       Impact factor: 20.096

2.  The effect of alpha-adrenergic antagonists in chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis of randomized controlled trials.

Authors:  Gang Yang; Qiang Wei; Hong Li; Yuru Yang; Sixiao Zhang; Qiang Dong
Journal:  J Androl       Date:  2006-07-26

3.  Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Daniel A Shoskes; Lawrence Hakim; Gamal Ghoniem; Charles L Jackson
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

4.  Words of wisdom. Re: Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. Nickel JC, Krieger JN, McNaughton-Collins M, et al; Chronic Prostatitis Collaborative Research Network. N Engl J Med 2008;359:2663-73.

Authors:  Anthony J Schaeffer
Journal:  Eur Urol       Date:  2009-07       Impact factor: 20.096

5.  The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network.

Authors:  M S Litwin; M McNaughton-Collins; F J Fowler; J C Nickel; E A Calhoun; M A Pontari; R B Alexander; J T Farrar; M P O'Leary
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

6.  Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial.

Authors:  Richard B Alexander; Kathleen J Propert; Anthony J Schaeffer; J Richard Landis; J Curtis Nickel; Michael P O'Leary; Michel A Pontari; Mary McNaughton-Collins; Daniel A Shoskes; Craig V Comiter; Nand S Datta; Jackson E Fowler; Robert B Nadler; Scott I Zeitlin; Jill S Knauss; Yanlin Wang; John W Kusek; Leroy M Nyberg; Mark S Litwin
Journal:  Ann Intern Med       Date:  2004-10-19       Impact factor: 25.391

Review 7.  Role of alpha-blockers in type III prostatitis: a systematic review of the literature.

Authors:  Vibhash C Mishra; John Browne; Mark Emberton
Journal:  J Urol       Date:  2007-01       Impact factor: 7.450

8.  Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial.

Authors:  J Curtis Nickel; Joe Downey; Janet Clark; Richard W Casey; Peter J Pommerville; Jack Barkin; Gary Steinhoff; Gerald Brock; Allan B Patrick; Stanley Flax; Bernard Goldfarb; Bruce W Palmer; Joseph Zadra
Journal:  Urology       Date:  2003-10       Impact factor: 2.649

9.  Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis.

Authors:  J Curtis Nickel; Jim Xiang
Journal:  J Urol       Date:  2008-03-04       Impact factor: 7.450

10.  Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.

Authors:  J Curtis Nickel; Perinchery Narayan; John McKay; Caroline Doyle
Journal:  J Urol       Date:  2004-04       Impact factor: 7.450

View more
  7 in total

Review 1.  Minimally invasive therapies for chronic pelvic pain syndrome.

Authors:  Salim A Wehbe; Jennifer Y Fariello; Kristene Whitmore
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

Review 2.  The role of phenotyping in chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Brandon A Mahal; Jeffrey M Cohen; Stephen A Allsop; John B Moore; Salman F Bhai; Gino Inverso; Jordan D Dimitrakoff
Journal:  Curr Urol Rep       Date:  2011-08       Impact factor: 3.092

Review 3.  Pelvic floor therapies in chronic pelvic pain syndrome.

Authors:  Ragi Doggweiler; Adam F Stewart
Journal:  Curr Urol Rep       Date:  2011-08       Impact factor: 3.092

Review 4.  The DABBEC phenotyping system: towards a mechanistic understanding of CP/CPPS.

Authors:  Stephen A Allsop; Derek J Erstad; Karolina Brook; Salman F Bhai; Jeffrey M Cohen; Jordan D Dimitrakoff
Journal:  Nat Rev Urol       Date:  2011-01-18       Impact factor: 14.432

5.  The evolving clinical picture of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): A look at 1310 patients over 16 years.

Authors:  R Christopher Doiron; Dean A Tripp; Victoria Tolls; J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2018-02-23       Impact factor: 1.862

6.  Pain, catastrophizing, and depression in chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Jong Kyou Kwon; In Ho Chang
Journal:  Int Neurourol J       Date:  2013-06-30       Impact factor: 2.835

7.  Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis.

Authors:  Hong-Jun Li; De-Ying Kang
Journal:  World J Urol       Date:  2015-11-06       Impact factor: 4.226

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.